bioRxivBioengineering
"Organoid-in-a-column" coupled on-line with liquid chromatography-mass spectrometry
S. Kogler, A. Aizenshtadt, S. Harrison, F. S. Skottvoll, H. E. Berg, S. Abadpour, H. Scholz, G. Sullivan, B. Thiede, E. Lundanes, I. L. Bogen, S. Krauss, H. Roberg-Larsen, S. R. Wilson
Abstract
Organoids, i.e. laboratory-grown organ models developed from stem cells, are emerging tools for studying organ physiology, disease modeling and drug development. On-line analysis of organoids with mass spectrometry would provide analytical versatility and automation. To achieve these features with robust hardware, we have loaded liquid chromatography column housings with induced pluripotent stem cell (iPSC) derived liver organoids and coupled the "organ-in-a-column" units on-line with liquid chromatography-mass spectrometry (LC-MS). Liver organoids were co-loaded with glass beads to achieve an even distribution of organoids throughout the column while preventing clogging. The liver organoids were interrogated "on column" with heroin, followed by on-line monitoring of the drugs phase 1 metabolism. Enzymatic metabolism of heroin produced in the "organ-in-a-column" units was detected and monitored using a triple quadrupole MS instrument, serving as a proof-of-concept for on-line coupling of liver organoids and mass spectrometry. Taken together, the technology allows direct integration of liver organoids with LC-MS, allowing selective and automated tracking of drug metabolism over time.
- organism: human
- assay: organoid / primary culture
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Electromembrane extraction and mass spectrometry for liver organoid drug metabolism studies
F. S. Skottvoll, F. Hansen, … S. R. Wilson·bioRxiv·May 15, 2020
- Determination of insulin secretion from stem cell-derived islets with liquid chromatography-tandem mass spectrometry
C. Olsen, C. Wang, … S. R. Wilson·Journal of Chromatography BPeer-reviewed·Jan 1, 2023
- Organobodies: A robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screening
Mostafa Kiamehr, Stefano Manzini, … Catherine M. Verfaillie·BiofabricationPeer-reviewed·Apr 15, 2026
- Simultaneous LC-MS determination of glucose regulatory peptides secreted by stem cell-derived islet organoids
C. Olsen, C. Wang, … S. R. Wilson·ELECTROPHORESISPeer-reviewed·Aug 13, 2023
- Comparison of hiPSC-derived hepatic organoids and liver-on-a-chip systems reveal microenvironment-driven maturation
Isabel Tamargo-Rubio, Tim Krempel, … Jingyuan Fu·bioRxiv·Jul 29, 2026
- A hollow fiber membrane-based liver organoid-on-a-chip model for examining drug metabolism and transport
Adam Myszczyszyn, Anna Muench, … Bart Spee·BiofabricationPeer-reviewed·Mar 21, 2025